06 Mar 2023 Mithra announces promising topline safety results from Donesta® Phase 3 Study in North America Member news
02 Mar 2023 Mithra announces compelling initial preclinical data in its research collaboration on novel tyrosine kinase inhibitors with BCI Pharma Member news
01 Mar 2023 Sequana Medical announces positive results from CHIHUAHUA, Phase 1 clinical trial of second-generation DSR product for congestive heart failure Member news
09 Feb 2023 Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn’s disease Member news
08 Feb 2023 Sequana Medical announces the successful completion of pre-clinical studies with its second-generation DSR product for congestive heart failure Member news
18 Jan 2023 Annals of the Rheumatic Diseases publishes results from two bimekizumab Phase 3 studies in axial spondyloarthritis Member news
16 Dec 2022 Oxurion announces the continuation of KALAHARI Phase 2, Part B Study in diabetic macular edema following interim analysis Member news
09 Dec 2022 UCB announces positive Phase 3 studies for bimekizumab in hidradenitis suppurativa Member news
21 Nov 2022 Oxurion: Interim analysis for KALAHARI trial planned by year-end 2022 with full top-line data expected in second half of 2023 Member news
15 Nov 2022 Rejuvenate Biomed’s newly appointed Clinical Advisory Board endorses Clinical Phase 2b strategy in sarcopenia Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
